Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In silico strategies for modeling membrane transporter function.

Cheng Chang1, Abhijit Ray, Peter Swaan

  • 1Biophysics Program, Ohio State University, Columbus, Ohio, USA.

Drug Discovery Today
|May 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Doping induced enhancement for acetone sensing in ceria.

Scientific reports·2026
Same author

Doping induced enhancement for acetone sensing in ceria.

Scientific reports·2026
Same author

Gd-doped ceria with extraordinary oxygen-ion conductivity for low temperature solid oxide fuel cells.

Scientific reports·2024
Same author

Photovoltaic nanocells for high-performance large-scale-integrated organic phototransistors.

Nature nanotechnology·2024
Same author

Wheat MIXTA-like Transcriptional Activators Positively Regulate Cuticular Wax Accumulation.

International journal of molecular sciences·2024
Same author

No association between hepatitis C virus infection and risk of colorectal cancer: a systematic review and meta-analysis of cohort studies.

Frontiers in medicine·2024

Transporter proteins are key drug targets, but their complex structures hinder substrate design. New fusion models combining functional and structural data improve predictions for drug development.

Area of Science:

  • Pharmacology
  • Structural Biology
  • Computational Chemistry

Background:

  • Transporter proteins are crucial for drug absorption, distribution, and excretion.
  • Their substrate promiscuity makes them valuable pharmacological targets.
  • Limited high-resolution structural data has historically impeded rational drug design for transporters.

Purpose of the Study:

  • To address the challenge of designing transporter substrates due to limited structural information.
  • To develop novel predictive models by integrating diverse data types.
  • To enhance the understanding of transporter-substrate interactions for drug development.

Main Methods:

  • Generating fusion models by merging substrate-based structure-activity relationships (SARs).

Related Experiment Videos

  • Incorporating protein-based homology structures into the models.
  • Utilizing currently available functional and structural data.

    • Main Results:

    • The developed fusion models offer enhanced predictive capabilities for transporter substrates.
    • These models extend the predictive power beyond single-modality approaches.
    • Successful integration of SARs and structural data was achieved.

    Conclusions:

    • Fusion models represent a promising scaffold for intelligent transporter substrate design.
    • This approach overcomes limitations posed by sparse structural data.
    • The models facilitate improved drug absorption, reduced toxicity, and targeted delivery.